Clinical Trials
4 trialsNCT07612007 2026-06-01
HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
Mayo Clinic
Phase 2 Not yet recruiting
NCT06820320 2026-03-06
Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Completed
NCT03407963 2025-12-04
CAPEMBOL
Centre Hospitalier Universitaire de NÄ«mes
Phase NA Completed
NCT02577055 2025-11-20
Lune2
Assistance Publique - Hôpitaux de Paris
Phase NA Completed